Drug profile · INN
topiroxostat
TOPILORIC/URIADEC
topiroxostat (TOPILORIC/URIADEC) is a xanthine dehydrogenase inhibitor.
PMDA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — topiroxostat
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.78
Quick answer
topiroxostat (TOPILORIC/URIADEC) is a xanthine dehydrogenase inhibitor.
Key facts
INN topiroxostat
Brand TOPILORIC/URIADEC
Mechanism Xanthine dehydrogenase inhibitor
Target Xanthine dehydrogenase/oxidase
Mechanism of action
Xanthine dehydrogenase inhibitor
Primary target: Xanthine dehydrogenase/oxidase
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is topiroxostat?
topiroxostat (TOPILORIC/URIADEC) is a xanthine dehydrogenase inhibitor.
What is the brand name for topiroxostat?
TOPILORIC/URIADEC is a marketed brand name for topiroxostat. Check FDA Drugs@FDA for the current US label holder and prescribing information.